The presence of an immune response to prostate cancer can be seen in the form of tumor infiltrating lymphocytes (TILs) [11], particularly CD8+ T cells, which have been shown to be a positive prognostic factor in this disease and others [12,13,14]. This evidence concerns the gene CD8A and prostate cancer.